These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 3914827)

  • 1. alpha-Glucosidase inhibition in obesity.
    William-Olsson T
    Acta Med Scand Suppl; 1985; 706():1-39. PubMed ID: 3914827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of disaccharide digestion in rat intestine by the alpha-glucosidase inhibitor acarbose (BAY g 5421).
    Krause HP; Keup U; Puls W
    Digestion; 1982; 23(4):232-8. PubMed ID: 6754513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of an alpha-glucoside hydrolase inhibitor on glycemia and the absorption of sucrose in man determined using a tracer method.
    Radziuk J; Kemmer F; Morishima T; Berchtold P; Vranic M
    Diabetes; 1984 Mar; 33(3):207-13. PubMed ID: 6365657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of a glucosidase inhibitor (acarbose, BAY g 5421) on the development of obesity and food motivated behavior in Zucker (fafa) rats.
    Vasselli JR; Haraczkiewicz E; Maggio CA; Greenwood MR
    Pharmacol Biochem Behav; 1983 Jul; 19(1):85-95. PubMed ID: 6622510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic abnormalities in the genetically obese and diabetic Otsuka Long-Evans Tokushima Fatty rat can be prevented and reversed by alpha-glucosidase inhibitor.
    Yamamoto M; Jia DM; Fukumitsu KI; Imoto I; Kihara Y; Hirohata Y; Otsuki M
    Metabolism; 1999 Mar; 48(3):347-54. PubMed ID: 10094112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduction of carbohydrate-induced hypertriglyceridemia in (fa,fa) "Zucker" rats by the alpha-glucosidase inhibitor acarbose (BAY g 5421).
    Krause HP; Keup U; Thomas G; Puls W
    Metabolism; 1982 Jul; 31(7):710-4. PubMed ID: 7045575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adaptation of the small intestine to induced maldigestion in rats. Experimental pancreatic atrophy and acarbose feeding.
    Creutzfeldt W; Fölsch UR; Elsenhans B; Ballmann M; Conlon JM
    Scand J Gastroenterol Suppl; 1985; 112():45-53. PubMed ID: 3892654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modification of weight gain by an alpha-glucosidase inhibitor during refeeding in rats.
    Kotler DP; Tierney AR; Kral JG; Bjorntorp P
    Am J Clin Nutr; 1984 Aug; 40(2):270-6. PubMed ID: 6380264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improvement of metabolic control in insulin dependent diabetics treated with the alpha-glucosidase inhibitor acarbose for two months.
    Gérard J; Luyckx AS; Lefebvre PJ
    Diabetologia; 1981 Nov; 21(5):446-51. PubMed ID: 7028558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Scope and specificity of acarbose in slowing carbohydrate absorption in man.
    Jenkins DJ; Taylor RH; Goff DV; Fielden H; Misiewicz JJ; Sarson DL; Bloom SR; Alberti KG
    Diabetes; 1981 Nov; 30(11):951-4. PubMed ID: 7028548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of graded alpha-glucosidase inhibition on sugar absorption in vivo.
    Madariaga H; Lee PC; Heitlinger LA; Lebenthal E
    Dig Dis Sci; 1988 Aug; 33(8):1020-4. PubMed ID: 3292164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Response of serum levels of gastric inhibitory polypeptide and insulin to sucrose ingestion during long-term application of acarbose.
    Fölsch UR; Ebert R; Creutzfeldt W
    Scand J Gastroenterol; 1981; 16(5):629-32. PubMed ID: 7034156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acarbose reduces blood pressure in sucrose-induced hypertension in rats.
    Madar Z; Melamed EC; Zimlichman R
    Isr J Med Sci; 1997 Mar; 33(3):153-9. PubMed ID: 9313782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enteroglucagon release in disaccharide malabsorption induced by intestinal alpha-glucosidase inhibition.
    Hayakawa T; Kondo T; Okumura N; Nagai K; Shibata T; Kitagawa M
    Am J Gastroenterol; 1989 May; 84(5):523-6. PubMed ID: 2655436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Positive effects of acarbose in the diabetic rat are not altered by feeding schedule.
    Wright BE; Vasselli JR; Katovich MJ
    Physiol Behav; 1998 Mar; 63(5):867-74. PubMed ID: 9618010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitory effect of black tea and its combination with acarbose on small intestinal α-glucosidase activity.
    Satoh T; Igarashi M; Yamada S; Takahashi N; Watanabe K
    J Ethnopharmacol; 2015 Feb; 161():147-55. PubMed ID: 25523370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of acarbose (BAY-g-5421) on expression of noninsulin-dependent diabetes mellitus in sucrose-fed SHR/N-corpulent rats.
    Carswell N; Michaelis OE; Prather ES
    J Nutr; 1989 Mar; 119(3):388-94. PubMed ID: 2646401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of the alpha-glucosidase inhibitor BAY g 5421 (Acarbose) on meal-stimulated elevations of circulating glucose, insulin, and triglyceride levels in man.
    Hillebrand I; Boehme K; Frank G; Fink H; Berchtold P
    Res Exp Med (Berl); 1979 Apr; 175(1):81-6. PubMed ID: 375342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A risk-benefit appraisal of acarbose in the management of non-insulin-dependent diabetes mellitus.
    Santeusanio F; Compagnucci P
    Drug Saf; 1994 Dec; 11(6):432-44. PubMed ID: 7727053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exocrine and endocrine pancreatic function in rats treated with alpha-glucosidase inhibitor (acarbose).
    Otsuki M; Sakamoto C; Ohki A; Okabayashi Y; Yuu H; Maeda M; Baba S
    Metabolism; 1983 Aug; 32(8):846-50. PubMed ID: 6191180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.